Investors Are Eying: SCYNEXIS (NASDAQ:SCYX), Itau Unibanco Holding SA (NYSE:ITUB), Ligand Pharmaceuticals Incorporated (NASDAQ:LGND), Enphase Energy (NASDAQ:ENPH), CommunityOne Bancorp (NASDAQ:COB)

Drug discovery and development company SCYNEXIS, Inc. (NASDAQ:SCYX) announced that the U.S. Food & Drug Administration (FDA) has granted Fast Track designation for the oral formulation of SCY-078, the Company’s novel antifungal product in development for the treatment of invasive Candidiasis, including Candidemia and invasive Aspergillosis. SCYNEXIS is currently screening patients for a Phase 2 study of the oral formulation of SCY-078 and expects to enroll the first patient in the first quarter of 2015. On Friday shares of SCYNEXIS, Inc. (NASDAQ:SCYX) closed at $12.84.

Itau Unibanco Holding SA (NASDAQ:ITUB) has been given a “BBB+” credit rating by analysts at Morningstar. The firm’s “BBB+” rating suggests that the company is a moderate default risk. They also gave their stock a three star rating. Itau Unibanco Holding SA (ADR) (NYSE:ITUB) in last trading activity decreased -2.45% to close at $13.15. Company weekly performance is 4.61% while its quarterly performance stands at -14.50%. Itau Unibanco Holding SA (ADR) (NYSE:ITUB) is -28.76% away from its 52 week high.

Ligand Pharmaceuticals Inc. (NASDAQ:LGND) said its partner Retrophin, Inc. has received orphan drug designation from the U.S. Food and Drug Administration or FDA for Sparsentan for the treatment of focal segmental glomerulosclerosis or FSGS. On Friday shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) closed at $54.95. Company’s sales growth for last 5 years was 12.40% and EPS growth for next 5 years is recorded as 48.09%.

On Dec 30, Enphase Energy, Inc. (NASDAQ:ENPH) , announced t that the company will be presenting at the 17th Annual Needham Growth Conference taking place January 13, 2015, at the New York Palace Hotel in New York. Enphase Energy, Inc. (NASDAQ:ENPH) has 12.80% insider ownership while its institutional ownership stands at 80.70%. In last trading activity company’s stock closed at $11.53.

On Dec 30, CommunityOne Bancorp (NASDAQ:COB), announced that it completed a private placement of $25 million of its common stock, positioning the Company to grow its earning assets, including its loan portfolio, in 2015. On last trading day CommunityOne Bancorp (NASDAQ:COB) decreased -3.78% to close at $10.45. Its volatility for the week is 1.74% while volatility for the month is 3.82%. COB’s sales growth for past 5 years was -8.00% and its EPS growth for past 5 years was 83.20%. CommunityOne Bancorp (NASDAQ:COB) monthly performance is 1.46%.

Leave a Reply

Your email address will not be published. Required fields are marked *